Associated Banc-Corp’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,540
| Closed | -$206K | – | 316 |
|
|
2023
Q4 | $206K | Sell |
2,540
-627
| -20% | -$48.8K | 0.01% | 305 |
|
|
2023
Q3 | $237K | Hold |
3,167
| – | – | 0.01% | 277 |
|
|
2023
Q2 | $244K | Sell |
3,167
-1,249
| -28% | -$99.6K | 0.01% | 284 |
|
|
2023
Q1 | $366K | Sell |
4,416
-1,025
| -19% | -$84.9K | 0.01% | 251 |
|
|
2022
Q4 | $467K | Sell |
5,441
-171
| -3% | -$13.5K | 0.02% | 232 |
|
|
2022
Q3 | $346K | Hold |
5,612
| – | – | 0.02% | 247 |
|
|
2022
Q2 | $347K | Buy |
5,612
+25
| +0.4% | +$1.55K | 0.02% | 252 |
|
|
2022
Q1 | $332K | Sell |
5,587
-166
| -3% | -$10.6K | 0.01% | 268 |
|
|
2021
Q4 | $418K | Sell |
5,753
-1,375
| -19% | -$94.7K | 0.02% | 247 |
|
|
2021
Q3 | $497K | Sell |
7,128
-865
| -11% | -$60.8K | 0.02% | 232 |
|
|
2021
Q2 | $550K | Sell |
7,993
-11,317
| -59% | -$756K | 0.02% | 228 |
|
|
2021
Q1 | $1.44M | Buy |
19,310
+5,838
| +43% | +$376K | 0.09% | 146 |
|
|
2020
Q4 | $785K | Sell |
13,472
-2,730
| -17% | -$165K | 0.03% | 234 |
|
|
2020
Q3 | $1.02M | Sell |
16,202
-2,772
| -15% | -$192K | 0.04% | 201 |
|
|
2020
Q2 | $1.46M | Sell |
18,974
-2,736
| -13% | -$210K | 0.07% | 181 |
|
|
2020
Q1 | $1.62M | Buy |
21,710
+4,028
| +23% | +$278K | 0.09% | 164 |
|
|
2019
Q4 | $1.15M | Sell |
17,682
-1,011
| -5% | -$65.8K | 0.06% | 180 |
|
|
2019
Q3 | $1.19M | Sell |
18,693
-1,426
| -7% | -$93.2K | 0.06% | 175 |
|
|
2019
Q2 | $1.36M | Sell |
20,119
-17
| -0.1% | -$1.12K | 0.07% | 166 |
|
|
2019
Q1 | $1.31M | Sell |
20,136
-541
| -3% | -$36K | 0.08% | 169 |
|
|
2018
Q4 | $1.29M | Sell |
20,677
-4,677
| -18% | -$327K | 0.08% | 162 |
|
|
2018
Q3 | $1.96M | Sell |
25,354
-702
| -3% | -$53K | 0.11% | 145 |
|
|
2018
Q2 | $1.85M | Sell |
26,056
-4,679
| -15% | -$330K | 0.11% | 147 |
|
|
2018
Q1 | $2.32M | Sell |
30,735
-21,045
| -41% | -$1.67M | 0.13% | 135 |
|
|
2017
Q4 | $3.71M | Sell |
51,780
-11,708
| -18% | -$889K | 0.2% | 112 |
|
|
2017
Q3 | $5.14M | Sell |
63,488
-8,965
| -12% | -$686K | 0.28% | 86 |
|
|
2017
Q2 | $5.13M | Sell |
72,453
-39,436
| -35% | -$2.62M | 0.29% | 81 |
|
|
2017
Q1 | $7.6M | Sell |
111,889
-6,503
| -5% | -$457K | 0.45% | 64 |
|
|
2016
Q4 | $8.48M | Sell |
118,392
-7,467
| -6% | -$555K | 0.53% | 57 |
|
|
2016
Q3 | $9.96M | Sell |
125,859
-1,863
| -1% | -$151K | 0.63% | 50 |
|
|
2016
Q2 | $10.7M | Sell |
127,722
-7,223
| -5% | -$641K | 0.68% | 44 |
|
|
2016
Q1 | $12.4M | Sell |
134,945
-24,515
| -15% | -$2.21M | 0.81% | 38 |
|
|
2015
Q4 | $16.1M | Buy |
159,460
+2,157
| +1% | +$224K | 1.06% | 25 |
|
|
2015
Q3 | $15.4M | Sell |
157,303
-1,332
| -0.8% | -$148K | 1.08% | 23 |
|
|
2015
Q2 | $18.6M | Sell |
158,635
-21,054
| -12% | -$2.3M | 1.19% | 21 |
|
|
2015
Q1 | $17.6M | Sell |
179,689
-27,018
| -13% | -$2.74M | 1.11% | 24 |
|
|
2014
Q4 | $19.5M | Buy |
206,707
+1,011
| +0.5% | +$105K | 1.23% | 20 |
|
|
2014
Q3 | $21.9M | Sell |
205,696
-2,895
| -1% | -$283K | 1.44% | 12 |
|
|
2014
Q2 | $17.3M | Buy |
208,591
+28,746
| +16% | +$2.24M | 1.12% | 23 |
|
|
2014
Q1 | $12.7M | Buy |
179,845
+44,084
| +32% | +$3.46M | 0.88% | 32 |
|
|
2013
Q4 | $10.2M | Buy |
135,761
+7,974
| +6% | +$555K | 0.73% | 42 |
|
|
2013
Q3 | $8.03M | Sell |
127,787
-4,024
| -3% | -$240K | 0.64% | 48 |
|
|
2013
Q2 | $6.76M | Buy |
+131,811
| New | +$6.87M | 0.56% | 53 |
|
Other funds holding GILD
Associated Banc-Corp's GILD Position: Q1 2024 in Review
Associated Banc-Corp sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 2,540 shares — an estimated $206K sold.
Associated Banc-Corp first reported a position in GILD in Q2 2013 and held it in 43 quarters. The position peaked at $21.9M in Q3 2014. 1,722 funds tracked by Wall St. Rank hold GILD as of Q1 2024.
- Associated Banc-Corp reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
- Associated Banc-Corp sold 2,540 Gilead Sciences shares in Q1 2024, an estimated $206K.
- Associated Banc-Corp first reported a position in Gilead Sciences in Q2 2013 and held it in 43 quarters.
- Associated Banc-Corp's Gilead Sciences position peaked at $21.9M in Q3 2014.
- 1,722 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.
Based on Associated Banc-Corp's 13F filing for Q1 2024, filed 9 May 2024.